Bellevue Life Sciences Ac...

3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Ratios Statement

Year FY23 FY22 FY21 FY20
PE Ratio 146.22 -2.58K -24.21K -3.35K
PEG Ratio -0.08 -2.95 279.37 n/a
PS Ratio n/a n/a n/a n/a
PB Ratio 1.82 -2.44K -37.78K 67.08K
P/FCF Ratio -72.11 -21.6K -173.74K -3.35K
P/OCF Ratio -72.11 -21.6K -173.74K -3.35K
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio n/a -31.99 -188.68 252.53
Quick Ratio 0.01 0.10 0.01 0.19
Current Ratio 0.01 0.10 0.01 0.19
Asset Turnover n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a
Return on Equity (ROE) 0.01 0.94 1.56 -20.04
Return on Assets (ROA) 0.01 -0.03 -0.00 -0.07
Return on Capital (ROIC) -0.05 0.94 1.56 -20.04
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a